Compartir
Code of Federal Regulations Title 21, Volume 1, April 1, 2015 (en Inglés)
Office Of The Federal Register (Autor)
·
Regulations Press
· Tapa Blanda
Code of Federal Regulations Title 21, Volume 1, April 1, 2015 (en Inglés) - Office of the Federal Register
Libro Nuevo
Importado
Envío: 10 a 12 días háb.
₡ 41.947
Costos de importación y 13% IVA incluídos en el precio ✅
Reseña del libro "Code of Federal Regulations Title 21, Volume 1, April 1, 2015 (en Inglés)"
21 CFR Parts 0-99 covers a range of topics including general administrative rulings and decisions; to protection of privacy, environmental impact considerations, pharmaceutical manufacturing practices and reports for devices within the United States and European community; color additives in food, drugs, and cosmetics, and more.This volume would be appropriate for the general public, plus pharmacy and start up health care manufacturers, as well as food, drug, and cosmetic company personnel interested in developing products to be disseminated within the United States of America.Code of Federal Regulations Title 21, Volume 1, April 1, 2015Containing parts Parts 1 to 99Part 1; GENERAL ENFORCEMENT REGULATIONSPart 2; GENERAL ADMINISTRATIVE RULINGS AND DECISIONSPart 3; PRODUCT JURISDICTIONPart 4; REGULATION OF COMBINATION PRODUCTSPart 5; ORGANIZATIONPart 7; ENFORCEMENT POLICYPart 10; ADMINISTRATIVE PRACTICES AND PROCEDURESPart 11; ELECTRONIC RECORDS; ELECTRONIC SIGNATURESPart 12; FORMAL EVIDENTIARY PUBLIC HEARINGPart 13; PUBLIC HEARING BEFORE A PUBLIC BOARD OF INQUIRYPart 14; PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEEPart 15; PUBLIC HEARING BEFORE THE COMMISSIONERPart 16; REGULATORY HEARING BEFORE THE FOOD AND DRUG ADMINISTRATIONPart 17; CIVIL MONEY PENALTIES HEARINGSPart 19; STANDARDS OF CONDUCT AND CONFLICTS OF INTERESTPart 20; PUBLIC INFORMATIONPart 21; PROTECTION OF PRIVACYPart 25; ENVIRONMENTAL IMPACT CONSIDERATIONSPart 26; MUTUAL RECOGNITION OF PHARMACEUTICAL GOOD MANUFACTURING PRACTICE REPORTS, MEDICAL DEVICE QUALITY SYSTEM AUDIT REPORTS, AND CERTAIN MEDICAL DEVICE PRODUCT EVALUATION REPORTS: UNITED STATES AND THE EUROPEAN COMMUNITYPart 50; PROTECTION OF HUMAN SUBJECTSPart 54; FINANCIAL DISCLOSURE BY CLINICAL INVESTIGATORSPart 56; INSTITUTIONAL REVIEW BOARDSPart 58; GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIESPart 60; PATENT TERM RESTORATIONPart 70; COLOR ADDITIVESPart 71; COLOR ADDITIVE PETITIONSPart 73; LISTING OF COLOR ADDITIVES EXEMPT FROM CERTIFICATIONPart 74; LISTING OF COLOR ADDITIVES SUBJECT TO CERTIFICATIONPart 80; COLOR ADDITIVE CERTIFICATIONPart 81; GENERAL SPECIFICATIONS AND GENERAL RESTRICTIONS FOR PROVISIONAL COLOR ADDITIVES FOR USE IN FOODS, DRUGS, AND COSMETICSPart 82; LISTING OF CERTIFIED PROVISIONALLY LISTED COLORS AND SPECIFICATIONSParts 83-98; ReservedPart 99; DISSEMINATION OF INFORMATION ON UNAPPROVED/NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES
